Apoptotic effect of cleaved high molecular weight kininogen is regulated by extracellular matrix proteins

Journal of Cellular Biochemistry

Volumn 89, Issue 3, 2003, Pages 622-632

  Guo, Yan Lin ^a   Wang, Shujie ^a   Cao, Dian J ^a   Colman, Robert W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Apoptosis; Cell adhesion; Endothelial cells; Focal adhesion kinase

Indexed keywords

GELATIN; HIGH MOLECULAR WEIGHT KININOGEN; PAXILLIN; SCLEROPROTEIN; VITRONECTIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

APOPTOSIS; CELL ADHESION; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; KININOGENS; MOLECULAR WEIGHT; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES;

EID: 0038022596     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10536     Document Type: Article

References (45)

1. Aguirre Ghiso JA. 2002. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21:2513-2524.
2. Asakura S, Hurley RW, Skorstengaard K, Ohkubo I, Mosher DF. 1992. Inhibition of cell adhesion by high molecular weight kininogen. J Cell Biol 116:465-476.
3. Beckner ME. 1999. Factors promoting tumor angiogenesis. Cancer Invest 17:594-623.
4. Browder T, Folkman J, Pirie-Shepherd S. 2000. The hemostatic system as a regulator of angiogenesis. J Biol Chem 275:1521-1524.
5. Cao Y, Chen A, An SSA, Ji RW, Davidson D, Llinas M. 1997. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 272:22924-22928.
6. Chan PY, Kanner SB, Whitney G, Aruffo A. 1994. A transmembrane-anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK. J Biol Chem 269: 20567-20574.
7. Chapman HA. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9:714-724.
8. Chavakis T, Kanse SM, Lupu F, Hammes HP, MullerEsterl W, Pixley RA, Colman RW, Preissner KT. 2000. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 96: 514-522.
9. Colman RW. 1999. Biologic activities of the contact factors in vivo - potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis, and thrombosis. Thromb Haemost 82:1568-1577.
10. Colman RW, Schmaier AH. 1997. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90:3819-3843.
11. Colman RW, Pixley RA, Najamunnisa S, Yan W, Wang J, Mazar A, McCrae KR. 1997. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest 100:1481-1487.
12. Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. 2000. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood 95: 543-550.
13. Colman RW, Pixley RA, Sainz I, Song J, Isordia-Salas I, Muhamed MM, Powell KD, Mousa SA. 2003. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high molecular weight kininogen. J Thromb Haemost 1:164-170.
14. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
15. Frisch SM, Screaton RA. 2001. Anoikis mechanisms. Curr Opin Cell Biol 13:552-562.
16. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799.
17. Guo YL, Kang B, Yang LJ, Williamson JR. 1999. Tumor necrosis factor-alpha and ceramide induce cell death through different mechanisms in rat mesangial cells. Am J Physiol 276:F390-F397.
18. Guo YL, Wang S, Colman RW. 2001. Kininostatin, an angiogenic inhibitor, inhibits proliferation, and induces apoptosis of human endothelial cells. Arterioscler Thromb Vasc Biol 21:1427-1433.
19. Guo YL, Wang S, Colman RW. 2002. Kininostatin as an antiangiogenic inhibitor: What we know and what we do not know. Int Immunopharmacol 2:1931-1940.
20. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA. 1996. Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135:1383-1390.
21. Ingber DE. 2002. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res 91:877-887.
22. Kabir J, Lobo M, Zachary I. 2002. Staurosporine induces endothelial cell apoptosis via focal adhesion kinase dephosphorylation and focal adhesion disassembly independent of focal adhesion kinase proteolysis. Biochem J 367:145-155.
23. Kunapuli SP, DeLa Cadena RA, Colman RW. 1993. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains. J Biol Chem 268:2486-2492.
24. Levkau B, Herren B, Koyama H, Ross R, Raines EW. 1998. Caspase-mediated cleavage of focal adhesion kinase pp125FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med 187:579-586.
25. Nguyen DH, Webb DJ, Catling AD, Song Q, Dhakephalkar A, Weber MJ, Ravichandran KS, Gonias SL. 2000. Urokinase-type plasminogen activator stimulates the Ras/ERK signaling pathway and MCF-7 cell migration by a mechanism that requires FAK, Src, and Shc: Rapid dissociation of Grb2/Sos from Shc is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem 275:19382-19388.
26. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. 1997. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285.
27. Ossowski L, Aguirre-Ghiso JA. 2000. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration, and growth. Curr Opin Cell Biol 12:613-620.
28. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M. 2001. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 15: 1487-1489.
29. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA. 2000. Focal adhesion kinase: A regulator of focal adhesion dynamics and cell movement. Oncogene 19:5606-5613.
30. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. 2000. Ligand binding to integrins. J Biol Chem 275:21785-21788.
31. Preissner KT, Seiffert D. 1998. Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res 89:1-21.
32. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. 1994. Inhibition of anchoragedependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 127:537-546.
33. Rosales C, O'Brien V, Kornberg L, Juliano R. 1995. Signal transduction by cell adhesion receptors. Biochim Biophys Acta 1242:77-98.
34. Sheng N, Fairbanks MB, Heinrikson RL, Canziani G, Chaiken IM, Mosser DM, Zhang H, Colman RW. 2000. Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1. Blood 95:3788-3795.
35. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE. 1998. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 273:18268-18272.
36. Valentinis B, Reiss K, Baserga R. 1998. Insulin-like growth factor-I-mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase. J Cell Physiol 176:648-657.
37. van de WB, Nagelkerke JF, Stevens JL. 1999. Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem 274:13328-13337.
38. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380-32388.
39. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA. 1999. A role for caveolin and the urokinase receptor in integrinmediated adhesion and signaling. J Cell Biol 144:1285-1294.
40. Wei L, Yang Y, Hang X, Yu Q. 2002. Anchorage-independent phosphorylation of p130Cas protects lung adenocarcinoma cells from anoikis. J Cell Biochem 87:439-449.
41. Weisel JW, Nagaswami C, Woodhead JL, DeLa Cadena RA, Page JD, Colman RW. 1994. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem 269:10100-10106.
42. Widmann C, Gibson S, Johnson GL. 1998. Caspasedependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273:7141-7147.
43. Xu LH, Owens LV, Sturge GC, Yang X, Liu ET, Craven RJ, Cance WG. 1996. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 7:413-418.
44. Yu DH, Qu CK, Henegariu O, Lu X, Feng GS. 1998. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 273:21125-21131.
45. Zhang JC, Claffey K, Sakthivel R, Darzynkiewicz Z, Shaw DE, Leal J, Wang YC, Lu FM, McCrae KR. 2000. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: Partial activity within domain 5. FASEB J 14:2589-2600.